Patent · US Active

Methods of treating ocular and other diseases with Syn-134R polypeptide

US8491912B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2011
Grant dateJul 23, 2013
Priority date
Expiry dateJun 16, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/24033
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein TPV1 is a method of treating ocular and systemic conditions by administering IL-10 and TPV134R polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.